Arcturus Therapeutics Holdings (ARCT) Return on Sales (2018 - 2026)

Arcturus Therapeutics Holdings' Return on Sales history runs 9 years deep, the most recent figure standing at 0.27% for Q1 2026.

• Quarterly Return on Sales fell 27.0% year-over-year to 0.27% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (down 2.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Sales was 0.27% for Q1 2026 at Arcturus Therapeutics Holdings, down from 0.04% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q4 2022 and bottomed at 0.27% in Q1 2026.
• A 5-year average of 0.03% and a median of 0.01% in 2024 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales increased 30 bps — and 2026, when it slipped 27 bps.
• Arcturus Therapeutics Holdings' Return on Sales stood at 0.01% in 2022, then slumped by 151 bps to 0.0% in 2023, then plunged by 247 bps to 0.01% in 2024, then tumbled by 206 bps to 0.04% in 2025, then slumped by 580 bps to 0.27% in 2026.
• Business Quant data shows ARCT's Return on Sales at 0.27% in Q1 2026, 0.04% in Q4 2025, and 0.01% in Q3 2025.